Editorial
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. May 27, 2025; 17(5): 101823
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.101823
Minimally invasive approaches to small gastric stromal tumors: The less with the more
Lapo Bencini, Elvira Adinolfi
Lapo Bencini, Elvira Adinolfi, Department of Surgical Oncology, Careggi University and District Hospital, Careggi Main Florence University and Regional Hospital, Florence 50134, Italy
Author contributions: Bencini L and Adinolfi E contributed to the references search, reading, and preparation of the manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Lapo Bencini, MD, PhD, Senior Researcher, Department of Surgical Oncology, Careggi University and District Hospital, Careggi Main Florence University and Regional Hospital, 3 Brambilla Street, Florence 50134, Italy. lapbenc@tin.it
Received: September 27, 2024
Revised: February 20, 2025
Accepted: March 6, 2025
Published online: May 27, 2025
Processing time: 237 Days and 12.6 Hours
Core Tip

Core Tip: Survival after surgery for small, low-risk, gastric stromal tumors is excellent, with few perioperative complications and infrequent recurrences. Minimally invasive surgical approaches, such as laparoscopy, robotics, and endoscopy, should provide optimal clinical outcomes while maintaining oncologic adequacy. Although all of these methods have several strengths and limitations, instrument availability, clinical expertise, and need to preserve oncologic parameters play a crucial role in the choice of one over another.